Foradil Related Clinical Trials
Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) [Completed]
A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-Dose Inhaler (pMDI) or Oxis Turbuhaler [Completed]
A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD [Completed]
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®) [Completed]
Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease [Completed]
To Evaluate the Long-Term Safety of (R,R)-Formoterol in Subjects With COPD [Completed]
Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease [Completed]
Efficacy Safety Study of Arformoterol/Tio Combo vs. Either Therapy Alone in COPD [Completed]
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1) [Active, not recruiting]
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1) [Active, not recruiting]
Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers [Completed]
Perforomist vs. Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT) [Not yet recruiting]
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD [Active, not recruiting]
Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer) [Completed]
SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma [Completed]
Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) [Recruiting]
Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma [Recruiting]
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients [Recruiting]
Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma [Recruiting]
Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4) [Recruiting]
Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4) [Recruiting]
Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU [Recruiting]
Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics [Not yet recruiting]
Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations [Completed]
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients [Completed]
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects [Recruiting]
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma [Completed]
Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma [Completed]
Concentrations of Formoterol in Blood and Urine [Not yet recruiting]
New Combination Inhaler (Flutiform HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma [Active, not recruiting]
Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506) [Completed]
Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD [Completed]
Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1) [Recruiting]
Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics [Not yet recruiting]
Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD [Recruiting]
Dose-Response of Inhaled Formoterol [Not yet recruiting]
Study to Evaluate the Additional Effects of Tiotropium Plus Formoterol on Chronic Obstructive Pulmonary Disease (COPD) During Exercise [Recruiting]
Symbicort in Asthmatic Children - SEEDLING [Completed]
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 [Completed]
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 [Completed]
BDP/FF (Beclomethasone Dipropionate) Versus Formoterol Fumarate (FF) in Patients With Severe Chronic Obstructive Pulmonary Disease [Not yet recruiting]
Effect of Brovana and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Effects of Bronchodilator on Exercise Endurance Time and Breathlessness in Chronic Obstructive Pulmonary Disease (COPD): Cycle Ergometry Versus Treadmill [Recruiting]
Comparison Between Symbicort® and Prednisolone in COPD [Completed]
Aclidinium/Formoterol Fixed Combination Dose Finding Study [Recruiting]
A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD [Completed]
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED) [Completed]
EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI [Completed]
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects [Recruiting]
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD [Recruiting]
Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT [Recruiting]
A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma [Recruiting]
Rapid Onset Action of Salbutamol Versus Formoterol [Recruiting]
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease [Recruiting]
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease [Recruiting]
Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma [Recruiting]
An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-Severe Persistent, Reversible Asthma [Completed]
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD
Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction [Recruiting]
Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272) (COMPLETED) [Completed]
Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol [Completed]
Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma [Completed]
Budesonide / Formoterol in Treatment of Exacerbations of COPD
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate in the Treatment of Patients With COPD [Completed]
A 3-Week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma [Completed]
Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139AM1)(COMPLETED) [Completed]
Efficacy, Safety and Tolerability of Once-Daily (o.d.) Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily (b.i.d.) as Active Control
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma [Recruiting]
A Six-Week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in COPD [Completed]
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol [Recruiting]
Study of the Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations [Recruiting]
A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD [Completed]
CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE With An Adjustable Maintenance Dose Of SYMBICORT [Completed]
Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients [Recruiting]
Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand [Recruiting]
A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease [Not yet recruiting]
A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiFormâ„¢) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults [Recruiting]
Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol [Completed]
Evaluation of Safety and Efficacy of Symbicort pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma [Completed]
Study in Subjects Greater Than 40 Years of Age With COPD [Active, not recruiting]
Effect of Symbicort on GR Localisation in Asthma [Completed]
Single-Dose Crossover Study to Investigate Pharmacodynamics of AZD3199 [Recruiting]
Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Study in Patients With Asthma [Completed]
Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma [Completed]
A Crossover Study in the Treatment of Patients With COPD [Completed]
Study in Patients With Asthma [No longer recruiting]
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma [No longer recruiting]
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1) [Recruiting]
Study in Patients With COPD [No longer recruiting]
Study in Patients With COPD [No longer recruiting]
Mechanism(s)of Airflow Limitation in Moderate-Severe Persistent Asthma [Recruiting]
Safety and Efficacy of BI 1744 CL in Patients With COPD I [Not yet recruiting]
Safety and Efficacy of BI 1744 CL in Patients With COPD II [Recruiting]
Single-Dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma [Recruiting]
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice [Recruiting]
A Patient Handling Study of MF/F MDI With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703) [Recruiting]
A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma [Recruiting]
|
